Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.
Sullivan FJ, Herscher LL, Cook JA, Smith J, Steinberg SM, Epstein AH, Oldfield EH, Goffman TE, Kinsella TJ, Mitchell JB, et al. Sullivan FJ, et al. Among authors: mitchell jb. Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):583-90. doi: 10.1016/0360-3016(92)90944-d. Int J Radiat Oncol Biol Phys. 1994. PMID: 7928489 Clinical Trial.
Tumor hypoxia: chicken, egg, or a piece of the farm?
Coleman CN, Mitchell JB, Camphausen K. Coleman CN, et al. Among authors: mitchell jb. J Clin Oncol. 2002 Feb 1;20(3):610-5. doi: 10.1200/JCO.2002.20.3.610. J Clin Oncol. 2002. PMID: 11821437 No abstract available.
Development of investigational radiation modifiers.
Colevas AD, Brown JM, Hahn S, Mitchell J, Camphausen K, Coleman CN; Radiation Modifier Working Group of the National Cancer Institute. Colevas AD, et al. J Natl Cancer Inst. 2003 May 7;95(9):646-51. doi: 10.1093/jnci/95.9.646. J Natl Cancer Inst. 2003. PMID: 12734315 Review. No abstract available.
Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma.
Van Waes C, Chang AA, Lebowitz PF, Druzgal CH, Chen Z, Elsayed YA, Sunwoo JB, Rudy SF, Morris JC, Mitchell JB, Camphausen K, Gius D, Adams J, Sausville EA, Conley BA. Van Waes C, et al. Among authors: mitchell jb. Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1400-12. doi: 10.1016/j.ijrobp.2005.05.007. Epub 2005 Jul 11. Int J Radiat Oncol Biol Phys. 2005. PMID: 16005577
The chemistry and biology of nitroxide compounds.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB. Soule BP, et al. Among authors: mitchell jb. Free Radic Biol Med. 2007 Jun 1;42(11):1632-50. doi: 10.1016/j.freeradbiomed.2007.02.030. Epub 2007 Mar 12. Free Radic Biol Med. 2007. PMID: 17462532 Free PMC article. Review.
Therapeutic and clinical applications of nitroxide compounds.
Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB. Soule BP, et al. Among authors: mitchell jb. Antioxid Redox Signal. 2007 Oct;9(10):1731-43. doi: 10.1089/ars.2007.1722. Antioxid Redox Signal. 2007. PMID: 17665971 Review.
780 results